カテゴリ： MarketLine, インド, 企業調査

Karur Vysya Bank Ltd：企業の戦略・SWOT・財務情報

◆英語タイトル：Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C13593
◆発行会社（調査会社）：MarketLine
◆発行日：2019年2月
◆ページ数：41
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Karur Vysya Bank Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Karur Vysya Bank Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Karur Vysya Bank Ltd (KVB) provides a range of retail and corporate banking, and related financial solutions. It offers loans, deposit services, accounts and payment cards solutions. The bank provides loans for home, personal needs, professional requirements, vehicle, business, agriculture and education. It offers current, saving and demat accounts; fixed, recurring, tax shield, and monthly deposits; FCNR, NRO and NRE deposits; and debit, credit, travel and green card. KVB provides insurance coverage for health, general, travel, motor and household as an agent. The bank also offers services such as cash management, foreign exchange, online banking, treasury and investment banking. KVB is headquartered in Karur, Tamil Nadu, India.

Scope

- Detailed information on Karur Vysya Bank Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Karur Vysya Bank Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Karur Vysya Bank Ltd including a breakdown and examination of key business segments
- Intelligence on Karur Vysya Bank Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Karur Vysya Bank Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Karur Vysya Bank Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Karur Vysya Bank Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Karur Vysya Bank Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Karur Vysya Bank Ltd: Company Overview
Karur Vysya Bank Ltd: Overview and Key Facts
Karur Vysya Bank Ltd: Overview
Karur Vysya Bank Ltd: Key Facts
Karur Vysya Bank Ltd: Key Employees
Karur Vysya Bank Ltd: Key Employee Biographies
Karur Vysya Bank Ltd: Major Products and Services
Karur Vysya Bank Ltd: Company History
Karur Vysya Bank Ltd: Management Statement
Karur Vysya Bank Ltd: Locations and Subsidiaries
Karur Vysya Bank Ltd: Key Competitors
Karur Vysya Bank Ltd: Company Analysis
Karur Vysya Bank Ltd: Business Description
Karur Vysya Bank Ltd: SWOT Analysis
Karur Vysya Bank Ltd: SWOT Overview
Karur Vysya Bank Ltd: Strengths
Karur Vysya Bank Ltd: Weaknesses
Karur Vysya Bank Ltd: Opportunities
Karur Vysya Bank Ltd: Threats
Karur Vysya Bank Ltd: Corporate Financial Deals Activity
Karur Vysya Bank Ltd: Financial Deals Overview
Karur Vysya Bank Ltd: Top Deals 2015 – 2019YTD*
Karur Vysya Bank Ltd: Capital Raising
Karur Vysya Bank Ltd: Divestments
Karur Vysya Bank Ltd: Recent Developments
Karur Vysya Bank Ltd: News and Events Summary
Karur Vysya Bank Ltd: Business Expansion
Karur Vysya Bank Ltd: Corporate Governance
Karur Vysya Bank Ltd: Market Developments
Karur Vysya Bank Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Karur Vysya Bank Ltd: Key Facts
Table 2: Karur Vysya Bank Ltd: Key Employees
Table 3: Karur Vysya Bank Ltd: Company History
Table 4: Karur Vysya Bank Ltd: Locations and Subsidiaries
Table 5: Karur Vysya Bank Ltd: Key Competitors
Table 6: Karur Vysya Bank Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Karur Vysya Bank Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Karur Vysya Bank Ltd: Top Deals 2015 - 2019YTD*
Table 9: Karur Vysya Bank Ltd: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 10: Karur Vysya Bank Ltd: Capital Raising by Deal Type (2015 - YTD*2019)
Table 11: Karur Vysya Bank Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 12: Karur Vysya Bank Ltd: Divestments by Geography (2015 - YTD*2019)
Table 13: Karur Vysya Bank Ltd: News and Events Summary
Table 14: Karur Vysya Bank Ltd: Business Expansion
Table 15: Karur Vysya Bank Ltd: Corporate Governance
Table 16: Karur Vysya Bank Ltd: Market Developments
Table 17: Karur Vysya Bank Ltd: Strategy and Operations

List of Figures
Figure 1: Karur Vysya Bank Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Karur Vysya Bank Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Karur Vysya Bank Ltd: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 4: Karur Vysya Bank Ltd: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 5: Karur Vysya Bank Ltd: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 6: Karur Vysya Bank Ltd: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[Karur Vysya Bank Ltd：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • NuVasive Inc (NUVA)：製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Amtek Auto Limited：企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bashneft (BANE)-石油・ガス分野：企業M&A・提携分析
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • Information Services International-Dentsu Ltd (4812)：企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Formosa Laboratories Inc (4746)-製薬・医療分野：企業M&A・提携分析
    Summary Formosa Laboratories Inc (Formosa) is a healthcare products provider that develops ingredients. The company develops and markets active pharmaceutical ingredients and UV filters. Its active pharmaceutical ingredients comprise anticancers, cholesterol and phosphate binders, MRI enhancing agen …
  • AtriCure Inc (ATRC)：医療機器：M&Aディール及び事業提携情報
    Summary AtriCure, Inc. (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions. The company carries out the development, manufacture and sale of cardiac surgical ablation devices. Its major products include Isolator Synergy ablation system, …
  • China Development Bank：企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sompo Holdings Inc：企業の戦略・SWOT・財務分析
    Sompo Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sompo Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nachi-Fujikoshi Corp (6474)：企業の財務・戦略的SWOT分析
    Nachi-Fujikoshi Corp (6474) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Entravision Communications Corporation (EVC)：企業の財務・戦略的SWOT分析
    Entravision Communications Corporation (EVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Dexus Property Group：企業のM&A・事業提携・投資動向
    Dexus Property Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexus Property Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Canadian Tire Corp Ltd (CTC.A)：企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Olon SpA：製薬・医療：M&Aディール及び事業提携情報
    Summary Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, aba …
  • Kolon Life Science Inc (102940)-製薬・医療分野：企業M&A・提携分析
    Summary Kolon Life Science Inc (KLS) carries out research and development, manufacture and commercialization of pharmaceutical products and active pharmaceutical ingredients (APIs). It develops innovative cell and gene therapeutics. The company's lead product is Invossa, first cell-mediated gene the …
  • S.C. Johnson & Son Inc：戦略・SWOT・企業財務分析
    S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report Summary S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Royal KPN N.V.：企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Chariot Oil & Gas Ltd (CHAR)：石油・ガス：M&Aディール及び事業提携情報
    Summary Chariot Oil & Gas Ltd (CHAR) is an oil and gas exploration company that create transformational stakeholder value through the discovery of material accumulations of hydrocarbons. The company provides services such as drilling and extracting services for oil and gas resources. It also offers …
  • Lung Biotechnology PBC：医療機器：M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …
  • Honda Motor Co Ltd (7267)：企業の財務・戦略的SWOT分析
    Honda Motor Co Ltd (7267) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HAI Argochem (HAI)：企業の財務・戦略的SWOT分析
    HAI Argochem (HAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆